Compare CAPR & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAPR | CARS |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 546.6M |
| IPO Year | 2011 | 2017 |
| Metric | CAPR | CARS |
|---|---|---|
| Price | $7.60 | $12.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $27.25 | $14.36 |
| AVG Volume (30 Days) | ★ 4.2M | 880.5K |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $723,239,000.00 |
| Revenue This Year | N/A | $0.41 |
| Revenue Next Year | $85.77 | $2.23 |
| P/E Ratio | ★ N/A | $19.92 |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $2.96 | $7.40 |
| 52 Week High | $40.37 | $14.02 |
| Indicator | CAPR | CARS |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 52.98 |
| Support Level | $7.78 | $10.71 |
| Resistance Level | $10.62 | $13.22 |
| Average True Range (ATR) | 1.18 | 0.67 |
| MACD | -0.11 | -0.10 |
| Stochastic Oscillator | 19.61 | 34.37 |
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.